1.Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy.
Jun Seop KIM ; Jong Hak LEE ; Owen KWON ; Jang Hee CHO ; Ji Young CHOI ; Sun Hee PARK ; Chan Duck KIM ; Yong Jin KIM ; Yong Lim KIM
Kidney Research and Clinical Practice 2017;36(2):200-204
Administration of autologous mesenchymal stem cells (MSCs) has been shown to improve renal function and histological findings in acute kidney injury (AKI) models. However, its effects in chronic kidney disease (CKD) are unclear, particularly in the clinical setting. Here, we report our experience with a CKD patient who was treated by intravenous infusion of autologous MSCs derived from adipose tissue in an unknown clinic outside of Korea. The renal function of the patient had been stable for several years before MSC administration. One week after the autologous MSC infusion, the preexisting renal insufficiency was rapidly aggravated without any other evidence of AKI. Hemodialysis was started 3 months after MSC administration. Renal biopsy findings at dialysis showed severe interstitial fibrosis and inflammatory cell infiltration, with a few cells expressing CD34 and CD117, 2 surface markers of stem cells. This case highlights the potential nephrotoxicity of autologous MSC therapy in CKD patients.
Acute Kidney Injury
;
Adipose Tissue
;
Biopsy
;
Dialysis
;
Fibrosis
;
Humans
;
Infusions, Intravenous
;
Korea
;
Mesenchymal Stromal Cells*
;
Renal Dialysis
;
Renal Insufficiency*
;
Renal Insufficiency, Chronic
;
Stem Cells
;
Transplantation, Autologous
2.Clinical analysis of single filtration plasmapheresis using continuous renal replacement therapy machines in kidney transplantation.
Eunsoo LIM ; Yujeong KIM ; Jong Cheol JEONG ; Inwhee PARK ; Heungsoo KIM ; Su Hyung LEE ; Chang Kwon OH ; Gyu Tae SHIN
Kidney Research and Clinical Practice 2017;36(2):192-199
BACKGROUND: Plasmapheresis has become an essential element of kidney transplantation (KT). In the present study, we report clinical outcomes of filtration plasmapheresis using continuous renal replacement therapy machines with a single filter for the first time in Korea. METHODS: We retrospectively analyzed six patients who underwent filtration plasmapheresis for KT in our center; plasmapheresis was performed using the Plasmaflex (Baxter®) with a TPE 2000 filter set (Baxter®) in our hemodialysis unit. Five percent albumin was used as the replacement fluid, and intravenous immunoglobulin G was administered after each plasmapheresis session. The target preoperative ABO isoagglutinin titer was less than 1:8. RESULTS: Filtration plasmapheresis was performed in four patients for ABO-incompatible KT, one for antibody-mediated rejection after KT, and the last one for positive T cell crossmatch. Altogether, 46 sessions of plasmapheresis were performed. ABO isoagglutinin titers successfully declined to or below the target level in all patients, and all patients successfully received KT with no significant antibody titer rebound. Acute antibody-mediated rejection and positive T cell crossmatch were well treated with filtration plasmapheresis, and no patient required fresh frozen plasma infusion for coagulopathy. There were one episode of hypotension and three of hypocalcemia. No patients experienced bleeding, infection, or allergic reaction. CONCLUSION: Filtration plasmapheresis was effective and safe. Although our result is from a single center, our protocol appears to be promising.
Filtration*
;
Hemorrhage
;
Humans
;
Hypersensitivity
;
Hypocalcemia
;
Hypotension
;
Immunoglobulin G
;
Kidney Transplantation*
;
Kidney*
;
Korea
;
Plasma
;
Plasmapheresis*
;
Renal Dialysis
;
Renal Replacement Therapy*
;
Retrospective Studies
3.Relationship between trajectories of serum albumin levels and technique failure according to diabetic status in peritoneal dialysis patients: A joint modeling approach.
Mehri KHOSHHALI ; Iraj KAZEMI ; S.Mohsen HOSSEINI ; Shiva SEIRAFIAN
Kidney Research and Clinical Practice 2017;36(2):182-191
BACKGROUND: In peritoneal dialysis, technique failure is an important metric to be considered. This study was performed in order to identify the relationship between trajectories of serum albumin levels and peritoneal dialysis technique failure on end-stage renal disease patients according to diabetic status. Furthermore, this study was performed to reveal predictors of serum albumin and technique failure simultaneously. METHODS: This retrospective cohort study included 300 (189 non-diabetic and 111 diabetic) end-stage renal disease patients on continuous ambulatory peritoneal dialysis treated in Al-Zahra Hospital, Isfahan, Iran, from May 2005 to March 2015. Bayesian joint modeling was carried out in order to determine the relationship between trajectories of serum albumin levels and peritoneal dialysis technique failure in the patients according to diabetic status. Death from all causes was considered as a competing risk. RESULTS: Using joint modeling approach, a relationship between trajectories of serum albumin with hazard of transfer to hemodialysis was estimated as −0.720 (95% confidence interval [CI], −0.971 to −0.472) for diabetic and −0.784 (95% CI, −0.963 to −0.587) for non-diabetic patients. From our findings it was showed that predictors of low serum albumin over time were time on peritoneal dialysis for diabetic patients and increase in age and time on peritoneal dialysis, history of previous hemodialysis, and lower body mass index in non-diabetic patients. CONCLUSION: The results of current study showed that controlling serum albumin over time in non-diabetic and diabetic patients undergoing continuous ambulatory peritoneal dialysis treatment can decrease risk of adverse outcomes during the peritoneal dialysis period.
Body Mass Index
;
Cohort Studies
;
Humans
;
Iran
;
Joints*
;
Kidney Failure, Chronic
;
Peritoneal Dialysis*
;
Peritoneal Dialysis, Continuous Ambulatory
;
Renal Dialysis
;
Retrospective Studies
;
Serum Albumin*
4.The feasibility of surgical salvage of thrombosed arteriovenous fistula by an interventional nephrologist.
Kidney Research and Clinical Practice 2017;36(2):175-181
BACKGROUND: Salvage of a thrombosed arteriovenous fistula (AVF) by secondary fistula conversion may be more effective than a conventional endovascular procedure for forearm fistula thrombosis. Surgical access procedures are an undeveloped area in interventional nephrology compared to endovascular procedures. Herein, the author report the results of surgical salvage of thrombosed AVFs by interventional nephrologists. METHODS: The author retrospectively analyzed 52 surgical salvage procedures for AVF thrombosis (radiocephalic fistula = 44 cases, brachiocephalic fistula = 8 cases) that were performed by interventional nephrologist between March 2007 and January 2016. RESULTS: Secondary fistula formation using the proximal vein was performed for 46 cases (88.5%); outflow rerouting was performed for two cephalic-arch stenosis cases (3.9%), simple thrombectomy was performed for two cases (3.9%), and a graft interposition was performed for two cases (3.9%). Technical success after the surgical procedures was achieved in 51 cases (98.1%), and 39 AVFs (75.0%) were prepared for immediate puncturing without catheter insertion. The primary and secondary patency rates for AVF at 6, 12, 18, and 24 months were 88.5%, 83.2%, 83.2%, and 83.2% and 96.0%, 96.0%, 93.2%, and 93.2%, respectively. The re-intervention rate was 0.27 ± 0.92/patient/year. CONCLUSION: Based on these results, the author conclude that surgical salvage of a thrombosed AVF, when performed under local anesthesia by a skilled interventional nephrologist, offers favorable short- and long-term success and should be the preferred treatment.
Anesthesia, Local
;
Arteriovenous Fistula*
;
Catheters
;
Constriction, Pathologic
;
Endovascular Procedures
;
Fistula
;
Forearm
;
Nephrology
;
Retrospective Studies
;
Thrombectomy
;
Thrombosis
;
Transplants
;
Veins
5.The effect of the physical activity on polymorphic premature ventricular complexes in chronic kidney disease.
Márcio G KIUCHI ; Shaojie CHEN
Kidney Research and Clinical Practice 2017;36(2):167-174
BACKGROUND: Polymorphic premature ventricular complexes (PVCs) are very common, appearing most frequently in patients with hypertension, obesity, sleep apnea, and structural heart disease. Sympathetic hyperactivity plays a critical role in the development, maintenance, and aggravation of ventricular arrhythmias. Endurance exercise training clearly lowers sympathetic activity in sympatho-excitatory disease states and may be tolerated by patients with chronic kidney disease (CKD). METHODS: We assessed 40 CKD patients with hypertension with polymorphic PVCs. Patients underwent a complete medical history and physical examination. We evaluated the effectiveness of β blocker only or β blocker + exercise during 12 months of follow-up regarding the changes of the numbers of PVCs and mean heart rate (HR) by 24-hour-Holter. RESULTS: We observed in the β blocker group a significant decrease in the number of polymorphic PVCs from baseline 36,515 ± 3,518 to 3, 6, 9 and 12 months of follow-up, 28,314 ± 2,938, 23,709 ± 1,846, 22,564 ± 1,673, and 22,725 ± 1,415, respectively (P < 0.001). In the β blocker + exercise group a significant decrease in the number of polymorphic PVCs also occurred from baseline 36,091 ± 3,327 to 3, 6, 9 and 12 months of follow-up, 29,252 ± 3,211, 20,948 ± 2,386, 14,238 ± 3,338, and 6,225 ± 2,319, respectively (P < 0.001). Comparisons between the two groups at the same time point showed differences from the sixth month onwards: the 6th (Δ = −2,761, P = 0.045), 9th (Δ = −8,325, P < 0.001) and 12th (Δ = −16,500, P < 0.001) months. There was an improvement during the 12 months of follow-up vs. baseline, after the β blocker or β blocker + exercise in mean 24-hour HR Holter monitoring, creatinine values, eGFR, and ACR. CONCLUSION: Polymorphic PVCs may be modifiable by physical activity in CKD patients with hypertension without structural heart disease.
Arrhythmias, Cardiac
;
Creatinine
;
Electrocardiography, Ambulatory
;
Follow-Up Studies
;
Heart Diseases
;
Heart Rate
;
Humans
;
Hypertension
;
Motor Activity*
;
Obesity
;
Physical Examination
;
Renal Insufficiency, Chronic*
;
Sleep Apnea Syndromes
;
Ventricular Premature Complexes*
6.Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial.
Keiji HIRAI ; Susumu OOKAWARA ; Taisuke KITANO ; Haruhisa MIYAZAWA ; Kiyonori ITO ; Yuichirou UEDA ; Yoshio KAKU ; Taro HOSHINO ; Honami MORI ; Izumi YOSHIDA ; Kenji KUBOTA ; Yasuyoshi YAMAJI ; Tetsuro TAKEDA ; Yoshikazu NAKAMURA ; Kaoru TABEI ; Yoshiyuki MORISHITA
Kidney Research and Clinical Practice 2017;36(2):159-166
BACKGROUND: Mizoribine (MZR) is an immunosuppressive drug used in Japan for treating patients with lupus nephritis and nephrotic syndrome and has been also reportedly effective in patients with immunoglobulin A (IgA) nephropathy. However, to date, few randomized control studies of MZR are performed in patients with IgA nephropathy. Therefore, this prospective, open-label, randomized, controlled trial aimed to investigate the efficacy and safety of adding MZR to standard treatment in these patients, and was conducted between April 1, 2009, and March 31, 2016, as a multicenter study. METHODS: Patients were randomly assigned (1:1) to receiving standard treatment plus MZR (MZR group) or standard treatment (control group). MZR was administered orally at a dose of 150 mg once daily for 12 months. RESULTS: Primary outcomes were the percentage reduction in urinary protein excretion from baseline and the rate of patients with hematuria disappearance 36 months after study initiation. Secondary outcomes were the rate of patients with proteinuria disappearance, clinical remission rate, absolute changes in estimated glomerular filtration rate from baseline, and the change in daily dose of prednisolone. Forty-two patients were randomly assigned to MZR (n = 21) and control groups (n = 21). Nine patients in MZR group and 15 patients in the control group completed the study. No significant differences were observed between the two groups with respect to primary and secondary outcomes. CONCLUSION: The addition of MZR to standard treatment has no beneficial effect on reducing urinary protein excretion and hematuria when treating patients with IgA nephropathy.
Glomerular Filtration Rate
;
Glomerulonephritis, IGA*
;
Hematuria
;
Humans
;
Immunoglobulin A*
;
Immunoglobulins*
;
Japan
;
Lupus Nephritis
;
Nephrotic Syndrome
;
Prednisolone
;
Prospective Studies
;
Proteinuria
7.A unified pathogenesis for kidney diseases, including genetic diseases and cancers, by the protein-homeostasis-system hypothesis.
Kidney Research and Clinical Practice 2017;36(2):132-144
Every cell of an organism is separated and protected by a cell membrane. It is proposed that harmony between intercellular communication and the health of an organism is controlled by a system, designated the protein-homeostasis-system (PHS). Kidneys consist of a variety of types of renal cells, each with its own characteristic cell-receptor interactions and producing characteristic proteins. A functional union of these renal cells can be determined by various renal function tests, and harmonious intercellular communication is essential for the healthy state of the host. Injury to a kind of renal cells can impair renal function and induce an imbalance in total body health. Every acute or chronic renal disease has unknown etiologic substances that are responsible for renal cell injury at the molecular level. The immune/repair system of the host should control the etiologic substances acting against renal cells; if this system fails, the disease progresses to end stage renal disease. Each renal disease has its characteristic pathologic lesions where immune cells and immune proteins, such as immunoglobulins and complements, are infiltrated. These immune cells and immune proteins may control the etiologic substances involved in renal pathologic lesions. Also, genetic renal diseases and cancers may originate from a protein deficiency or malfunctioning protein under the PHS. A unified pathogenesis for renal diseases, including acute glomerulonephritis, idiopathic nephrotic syndrome, immunoglobulin A nephropathy, genetic renal diseases such as Alport syndrome, and malignancies such as Wilms tumor and renal cell carcinoma, is proposed using the PHS hypothesis.
Carcinoma, Renal Cell
;
Cell Membrane
;
Complement System Proteins
;
Glomerulonephritis
;
Glomerulonephritis, IGA
;
Hydrogen-Ion Concentration
;
Immunoglobulins
;
Kidney Diseases*
;
Kidney Failure, Chronic
;
Kidney*
;
Nephritis, Hereditary
;
Nephrotic Syndrome
;
Protein Deficiency
;
Renal Insufficiency, Chronic
;
Wilms Tumor
8.Renal sodium handling and sodium sensitivity.
Alissa A FRAME ; Richard D WAINFORD
Kidney Research and Clinical Practice 2017;36(2):117-131
The pathophysiology of hypertension, which affects over 1 billion individuals worldwide, involves the integration of the actions of multiple organ systems, including the kidney. The kidney, which governs sodium excretion via several mechanisms including pressure natriuresis and the actions of renal sodium transporters, is central to long term blood pressure regulation and the salt sensitivity of blood pressure. The impact of renal sodium handling and the salt sensitivity of blood pressure in health and hypertension is a critical public health issue owing to the excess of dietary salt consumed globally and the significant percentage of the global population exhibiting salt sensitivity. This review highlights recent advances that have provided new insight into the renal handling of sodium and the salt sensitivity of blood pressure, with a focus on genetic, inflammatory, dietary, sympathetic nervous system and oxidative stress mechanisms that influence renal sodium excretion. Increased understanding of the multiple integrated mechanisms that regulate the renal handling of sodium and the salt sensitivity of blood pressure has the potential to identify novel therapeutic targets and refine dietary guidelines designed to treat and prevent hypertension.
Blood Pressure
;
Genetics
;
Hypertension
;
Inflammation
;
Kidney
;
Natriuresis
;
Nutrition Policy
;
Oxidative Stress
;
Public Health
;
Sodium*
;
Sympathetic Nervous System
9.Middle East respiratory syndrome clinical practice guideline for hemodialysis facilities.
Hayne Cho PARK ; Young Ki LEE ; Sang Ho LEE ; Kyung Don YOO ; Hee Jung JEON ; Dong Ryeol RYU ; Seong Nam KIM ; Seung Hwan SOHN ; Rho Won CHUN ; Kyu Bok CHOI
Kidney Research and Clinical Practice 2017;36(2):111-116
The Korean Society of Nephrology participated in the task force team consisting of government authorities and civilian experts to prevent and control the spread of Middle East respiratory syndrome (MERS) in 2015. The Korean Society of Nephrology MERS Task Force Team took an immediate action and drafted ‘the clinical recommendation for hemodialysis facilities’ to follow when the first and the only confirmed case was reported in the hemodialysis unit. Owing to the dedicated support from medical doctors, dialysis nurses, and related medical companies, we could prevent further transmission of MERS infection successfully in hemodialysis units. This special report describes the experience of infection control during MERS outbreak in 2015 and summarizes the contents of ‘the clinical practice guideline for hemodialysis facilities dealing with MERS patients’ built upon our previous experience.
Advisory Committees
;
Coronavirus Infections*
;
Dialysis
;
Infection Control
;
Middle East Respiratory Syndrome Coronavirus
;
Middle East*
;
Nephrology
;
Quarantine
;
Renal Dialysis*
10.Anti-inflammatory and anti-apoptotic effects of paricalcitol in lipopolysaccharide-induced renal proximal tubular cell injury.
Kidney Research and Clinical Practice 2017;36(2):109-110
No abstract available.